Trump aims for role of NATO statesman but mars unity message
WATFORD, England — Aiming to play the role of global statesman as the impeachment drama was unfolding in Washington, President Donald Trump instead shattered NATO’s professed message of unity at its 70th anniversary celebration in England and put his personal and policy differences with alliance members on stark display.
Trump called Canadian Prime Minister Justin Trudeau “two-faced” and French President Emanuel Macron “nasty” during a 52-hour trip that exposed the alliance’s divisions on military budgets and relations with Turkey, as well as the U.S. leader’s own unconventional ways on the world stage.
At the same time, he found it difficult to leave behind events in Washington, lashing out as House Democrats resumed their push for impeachment over Trump’s call for Ukraine to investigate a political rival. He said it was “sad” that Democrats were pushing ahead with the inquiry when “there was no crime whatsoever and they know it.”
Trump, looking to showcase foreign policy wins as he heads into an election year, offered a more optimistic outlook for NATO’s future. He took credit for boosting the share of NATO nations that are meeting the alliance’s goal of spending 2% of gross domestic on defense and sought to pressure more countries to increase their military budgets. But he also put a spotlight on his administration’s lingering to-do list: ending a China trade war he instigated, passing the U.S.-Mexico-Canada agreement as well as trade deals with the European Union and Britain.
A day after Trudeau was overheard gossiping about Trump during a reception at Buckingham Palace, Trump called the Canadian leader “two-faced.” In an unguarded conversation, Trudeau told leaders, including Macron and British Prime Minister Boris Johnson, that “he takes a 40-minute press conference off the top,” an apparent reference to Trump’s long and unscheduled question-and-answer session with journalists earlier that day. Trudeau also said, seemingly about his meeting with Trump, “You just watched his team’s jaws drop to the floor.”
US Afghan peace envoy makes surprise stop in Kabul
KABUL, Afghanistan — Washington’s special peace envoy Zalmay Khalilzad was in the Afghan capital Kabul on Wednesday to launch an “accelerated effort” to get Afghans on both sides of the protracted conflict to the negotiation table to plot a roadmap to a post-war Afghanistan.
His next stop will be Doha in the Middle East where he will restart talks with the Taliban, according to a U.S. State Department statement. The talks would be the first official round since September when President Donald Trump declared an all but done deal dead after a surge in violence killed 12 people in the capital, including a U.S. soldier.
In Kabul on Wednesday, Khalilzad met with several Afghan leaders, including President Ashraf Ghani, who repeated his call for a cease-fire.
Hekmat Karzai, chairman of the Kabul-based Center for Conflict and Peace Studies, tweeted photographs of his meeting Wednesday with Khalilzad in Kabul, saying they “spoke about the way forward.”
A Taliban official said the group has held informal talks with the Americans, without specifying where or who participated. He spoke on condition of anonymity to discuss the talks.
Khalilzad’s visit comes just days after Trump visited U.S. troops in Afghanistan for the Thanksgiving holiday, when he hinted at a resumption of peace talks with the Taliban.
Drug can curb dementia’s delusions, researchers find
SAN DIEGO — A drug that curbs delusions in Parkinson’s patients did the same for people with Alzheimer’s disease and other forms of dementia in a study that was stopped early because the benefit seemed clear.
If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer’s in nearly two decades. It targets some of the most troubling symptoms that patients and caregivers face — hallucinations that often lead to anxiety, aggression, and physical and verbal abuse.
Results were disclosed Wednesday at a conference in San Diego.
“This would be a very important advance,” said one independent expert, Dr. Howard Fillit, chief science officer of the Alzheimer’s Drug Discovery Foundation.
Although the field is focused on finding a cure for dementia and preventing future cases, “there is a huge unmet need for better treatment” for those who have it now, said Maria Carrillo, the Alzheimer’s Association’s chief science officer.
Judge dismisses lawsuit in John Dillinger exhumation case
INDIANAPOLIS — A nephew of 1930s gangster John Dillinger needs a cemetery’s permission to exhume the notorious criminal’s Indianapolis gravesite to prove whether he’s actually buried there, a judge ruled Wednesday in dismissing the nephew’s lawsuit against the cemetery.
Marion County Superior Court Judge Timothy Oakes granted Crown Hill Cemetery’s motion to dismiss Michael Thompson’s lawsuit, saying Indiana law requires the cemetery’s consent.
“The limited question before the Court today is whether disinterment may occur under this section of the statute without cemetery approval. Court finds that the statutory requirements for this section of the statute are clear in that disinterment requires the cemetery owner to give consent before disinterment may occur,” Oakes wrote.
He added that Indiana law “does not require that the cemetery have a valid, rational, or meaningful reason” for withholding its consent.
Thompson sued the cemetery in August after it objected to his plans to exhume the grave as part of a television documentary. Thompson has said he has evidence Dillinger’s body may not be buried there, and that he may not have been the man FBI agents fatally shot outside a Chicago theater on July 22, 1934. The History Channel dropped out of the planned documentary in September.
